Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • rahularjun86
    Member
    • Jan 2011
    • 58

    velvet assemblies

    Dear all,
    I am doing an assembly of 40 Mb genome with expected coverage of 181x. I am using Illumina reads 76bp length with insert size 200 bp (Sd 20 bp). I have tried velvet for these assemblies and 86-99% of reads were used in this assembly with N50 of 80kb (with k-mer's 21,55,2). But the strange thing is that I am getting only 19 Mb genome after all assemblies. According to the staff whole genome has been covered during the library preparations.

    And secondly, should I turn off the velvet scaffolding before minimus2 assemblies/scaffolding??

    I would appreciate your suggestions.

    Thanks in advance
    Rahul
    Last edited by rahularjun86; 01-31-2012, 02:55 AM.
    Rahul Sharma,
    Ph.D
    Frankfurt am Main, Germany
  • nickloman
    Senior Member
    • Jul 2009
    • 355

    #2
    Assuming the genome is truly 40Mb, the most likely explanation is the presence of repeats.

    Try doing a plot of contig length versus k-mer coverage which will help you visualise the repeat structure of your genome (use the values in stats.txt produced by Velvet).

    Comment

    • nickloman
      Senior Member
      • Jul 2009
      • 355

      #3
      Also is your genome size calculation based on a haploid or diploid genome?

      Comment

      • rahularjun86
        Member
        • Jan 2011
        • 58

        #4
        Dear Nickloman, thank you so much for your reply. I am plotting the contig length vs k-mer coverage. It is haploid genome.
        Thanks,
        Rahul
        Rahul Sharma,
        Ph.D
        Frankfurt am Main, Germany

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          07-20-2026, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM
        • SEQadmin2
          Cancer Drug Resistance: The Lingering Barrier to Rising Survival
          by SEQadmin2



          Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

          There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
          07-08-2026, 05:17 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 07-24-2026, 12:17 PM
        0 responses
        26 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-23-2026, 11:41 AM
        0 responses
        21 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-20-2026, 11:10 AM
        0 responses
        210 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        78 views
        0 reactions
        Last Post SEQadmin2  
        Working...